Current CDC surveillance data confirm no active Level 4 Travel Health Notices, as no outbreaks meet the extreme-risk threshold of unmitigable transmission without available precautions. Ongoing Ebola Bundibugyo clusters in the Democratic Republic of the Congo and Uganda remain at Level 3 under enhanced screening, while hantavirus Andes virus cases linked to recent cruise-ship exposure show limited person-to-person spread and low U.S. importation risk per official assessments. Routine monitoring of chikungunya, malaria, and polio reflects contained patterns below historical escalation thresholds. Absent novel pathogen emergence or rapid case surges exceeding epidemiological baselines, trader consensus aligns with the 76.5% implied probability against issuance by year-end.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于是
$71,851 交易量
$71,851 交易量
2026-12-31
是
$71,851 交易量
$71,851 交易量
2026-12-31
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC surveillance data confirm no active Level 4 Travel Health Notices, as no outbreaks meet the extreme-risk threshold of unmitigable transmission without available precautions. Ongoing Ebola Bundibugyo clusters in the Democratic Republic of the Congo and Uganda remain at Level 3 under enhanced screening, while hantavirus Andes virus cases linked to recent cruise-ship exposure show limited person-to-person spread and low U.S. importation risk per official assessments. Routine monitoring of chikungunya, malaria, and polio reflects contained patterns below historical escalation thresholds. Absent novel pathogen emergence or rapid case surges exceeding epidemiological baselines, trader consensus aligns with the 76.5% implied probability against issuance by year-end.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
市场开放时间： Jan 19, 2026, 3:15 PM ET
交易量
$71,851结束日期
2026-12-31市场开放时间
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC surveillance data confirm no active Level 4 Travel Health Notices, as no outbreaks meet the extreme-risk threshold of unmitigable transmission without available precautions. Ongoing Ebola Bundibugyo clusters in the Democratic Republic of the Congo and Uganda remain at Level 3 under enhanced screening, while hantavirus Andes virus cases linked to recent cruise-ship exposure show limited person-to-person spread and low U.S. importation risk per official assessments. Routine monitoring of chikungunya, malaria, and polio reflects contained patterns below historical escalation thresholds. Absent novel pathogen emergence or rapid case surges exceeding epidemiological baselines, trader consensus aligns with the 76.5% implied probability against issuance by year-end.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
交易量
$71,851结束日期
2026-12-31市场开放时间
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Current CDC surveillance data confirm no active Level 4 Travel Health Notices, as no outbreaks meet the extreme-risk threshold of unmitigable transmission without available precautions. Ongoing Ebola Bundibugyo clusters in the Democratic Republic of the Congo and Uganda remain at Level 3 under enhanced screening, while hantavirus Andes virus cases linked to recent cruise-ship exposure show limited person-to-person spread and low U.S. importation risk per official assessments. Routine monitoring of chikungunya, malaria, and polio reflects contained patterns below historical escalation thresholds. Absent novel pathogen emergence or rapid case surges exceeding epidemiological baselines, trader consensus aligns with the 76.5% implied probability against issuance by year-end.
基于Polymarket数据的AI实验性摘要。这不是交易建议，也不影响该市场的结算方式。 · 更新于
警惕外部链接哦。
警惕外部链接哦。
常见问题